[ Price : $8.95]
Two Brookings Institution fellows suggest three steps to address the shortage of generic sterile injectable drugs.[ Price : $8.95]
FDA grants full approval to Amgens previously accelerated-approved BLA for Blincyto (blinatumomab) for treating certain adults and...[ Price : $8.95]
FDA launches a pilot program to post laboratory-developed test performance information using biomarkers to help facilitate better ...[ Price : $8.95]
FDA issues F2G Ltd. a complete response letter on its NDA for olorofim, an antifungal for invasive fungal infections in patients w...[ Price : $8.95]
FDA warns Tustin, CA-based Vitang Technology that its UniSmile Dental Aligner is misbranded and adulterated and thus is being sold...[ Price : $8.95]
FDA issues a clinical hold on Arcellxs CART-ddBCMA for treating patients with relapsed or refractory multiple myeloma, after a rec...[ Price : $8.95]
Federal Register notice: FDA announces an 8/22-23 advisory committee meeting to review a ReCor PMA and a Medtronic PMA for their d...[ Price : $8.95]
University of Pennsylvania medical school professor Jason Karlawish makes the case for FDA to require a detailed REMS for new Alzh...